Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Biogen Inc. (BIIB)

-NasdaqGS
398.68 Down 2.47(0.62%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:401.15
Open:399.19
Bid:N/A
Ask:400.50 x 200
1y Target Est:478.76
Beta:0.62
Earnings Date:Jul 21 - Jul 27 (Est.)
Day's Range:397.40 - 401.79
52wk Range:290.85 - 480.18
Volume:829,840
Avg Vol (3m):1,967,630
Market Cap:93.78B
P/E (ttm):28.80
EPS (ttm):13.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.62%93.78B
PFEDown 0.23%211.08B

Key Statistics

Forward P/E (1 yr):20.62
P/S (ttm):9.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :16.70
Quarterly EPS Est (Jun-15) :4.07
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback